Vimarsana
Biggest News Aggregation in the World

Deep Knowledge Ventures News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Deep Knowledge Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Deep Knowledge Ventures Today - Breaking & Trending Today

UAE's biggest company is adding an AI-powered observer backed by Microsoft to its board - Vimarsana News

UAE's biggest company is adding an AI-powered observer backed by Microsoft to its board

Aiden Insight’s role will include risk assessment and compliance monitoring. It will attend IHC board meetings as a non-voting observer.

Opinion: Soon, artificial intelligence will be running companies – rise of the robo-director - Vimarsana News

Opinion: Soon, artificial intelligence will be running companies – rise of the robo-director

‘Artificial governance intelligence’ is already being used for some boardrooms and corporate decision-making processes, including due diligence of mergers and acquisitions, auditing annual reports, and validating new business opportunities

Sentience and Sensibility | Meghan O'Gieblyn - Vimarsana News

Sentience and Sensibility | Meghan O'Gieblyn

The notion that capitalism metabolizes dissent is no longer theoretical but embodied in the architecture of its most profitable corporate technologies.

One-third of Mena's femtech companies are based in the UAE - Vimarsana News

One-third of Mena's femtech companies are based in the UAE

Kate Batz is the director of FemTech Analytics, ,managing partner at Longevity Capital as well as director of strategy and business...

Source: wamda.com
Deep Knowledge Group: Biomarkers of Human Longevity Are Essential for Investment De-Risking and Clinical Trial Predictability, Claims New Book by Seasoned Longevity Investor and Deep Knowledge Analytics Founder - Vimarsana News

Deep Knowledge Group: Biomarkers of Human Longevity Are Essential for Investment De-Risking and Clinical Trial Predictability, Claims New Book by Seasoned Longevity Investor and Deep Knowledge Analytics Founder

Dmitry Kaminskiy's New Book Urges Longevity Industry Players to Adopt Biomarkers of Human Longevity as the Fundamental Market-Ready Tool and Framework for Industry Stabilization, Tangible Decision